Korean Idiopathic Pulmonary Fibrosis Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04160715

Enrollment

3000

Registered

2019-11-13

Start date

2016-01-31

Completion date

2026-12-31

Last updated

2019-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis

Brief summary

This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.

Detailed description

Korean ILD Study Group includes investigators of 30 hospitals. Demographic, pulmonary function, laboratory data, chest CT findings and hospital course of IPF patients are collected.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to 100 Years

Healthy volunteers

Inclusion criteria

* IPF patients diagnosed by multidisciplinary discussion

Exclusion criteria

* Other interstitial lung diseases except for IPF * connective tissue disease-related ILD * exposure-related ILD

Design outcomes

Primary

Measure	Time frame	Description
survival of IPF	through study completion, an average of 1 year	lung function change (FVC, DLCO)

Secondary

Measure	Time frame	Description
survival	through study completion, an average of 1 year	death rate
acute exacerbation	through study completion, an average of 1 year	rate of acute exacerbation
incidence of comorbidity	through study completion, an average of 1 year	incidence of lung cancer

Countries

South Korea

Contacts

Primary ContactJong Sun Park, MD

jspark.im@gmail.com

Outcome results